Table 6.
Patients With Ciprofloxacin-Susceptible Organisms at Baseline and a Ciprofloxacin-Resistant Organism at Test of Cure: Microbiologic Modified Intent-to-Treat Population
| Parameter | Ertapenem/Ciprofloxacin, n (%) |
|---|---|
| Total number of positive TOC cultures obtained from patients with ciprofloxacin-susceptible isolates at baseline (N) | 35 |
| Total number (%) of isolates that were ciprofloxacin-resistant in TOC cultures | 16 (45.7) |
| Age, years | |
| ȃMean (SD) | 63.9 (19.5) |
| ȃMin, max | 24.0, 87.0 |
| Gender | |
| ȃMale | 2 (12.5%) |
| ȃFemale | 14 (87.5%) |
| Ethnicity | |
| ȃHispanic or Latinx | 1 (6.3) |
| ȃNot Hispanic or Latinx | 14 (87.5) |
| ȃNot reported | 1 (6.3) |
| Geographic region | |
| ȃNot the United States | 16 (100.0) |
| Race | |
| ȃWhite | 16 (100.0) |
| Diabetes mellitus | 2 (12.5) |
| Body mass index, mean (SD), kg/m2 | 25.9 (4.6) |
| Creatinine clearance,a mean (SD), mL/min | 66.9 (25.5) |
Abbreviations: SD, standard deviation; TOC, test of cure.aCalculated by Cockroft-Gault method.